EFFICACY AND SAFETY OF RANIBIZUMAB FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION DUE TO UNCOMMON CAUSE: Twelve-Month Results of the MINERVA Study

PURPOSE: To evaluate the efficacy and safety of ranibizumab 0.5 mg in adult patients with choroidal neovascularization because of an uncommon cause enrolled in the 12-month MINERVA study. METHODS: In this Phase III, double-masked study, adult (≥18 years) patients (N = 178) were randomized 2:1 to rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Timothy Y. Y., Staurenghi, Giovanni, Lanzetta, Paolo, Holz, Frank G., Melissa Liew, Shiao Hui, Desset-Brethes, Sabine, Staines, Harry, Hykin, Philip G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2018
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086222/
https://www.ncbi.nlm.nih.gov/pubmed/28704254
http://dx.doi.org/10.1097/IAE.0000000000001744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086222/
https://www.ncbi.nlm.nih.gov/pubmed/28704254
http://dx.doi.org/10.1097/IAE.0000000000001744

Ejemplares similares